Pharmesis International Ltd. (SGX:BFK)

Pharmesis International Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-4.3	8.28	-4.96	-3.56	1.17
Depreciation & Amortization	2.9	1.92	1.84	2	1.85
Loss (Gain) From Sale of Assets	-	-0.16	0.07	0.01	0.01
Asset Writedown & Restructuring Costs	-	-6.84	-	-	-
Provision & Write-off of Bad Debts	-0.62	0.45	0.17	0.2	0.01
Other Operating Activities	0.25	-0.88	3.49	0.34	1.01
Change in Accounts Receivable	20.53	-29.7	4.71	0.96	-1.64
Change in Inventory	-2.14	1.22	-7.76	-2.28	-0.27
Change in Accounts Payable	-13.58	19.08	0.81	0.74	0.14
Change in Other Net Operating Assets	-1.07	3.56	-9.96	8.16	-1.61
Operating Cash Flow	1.97	-3.07	-11.58	6.56	0.65
Operating Cash Flow Growth	-	-	-	905.21%	-61.38%
Capital Expenditures	-1.69	-1.17	-0.59	-0.24	-1.58
Sale of Property, Plant & Equipment	-	0.2	0.08	0.02	-
Cash Acquisitions	-	-2.83	-	-	-
Other Investing Activities	-	-	-0.07	-	-
Investing Cash Flow	-1.69	-3.8	-0.58	-0.22	-1.58
Short-Term Debt Issued	15	15	15	30	15
Total Debt Issued	15	15	15	30	15
Short-Term Debt Repaid	-15	-15	-15	-30	-15
Long-Term Debt Repaid	-0.57	-0.61	-0.21	-0.6	-0.28
Total Debt Repaid	-15.57	-15.61	-15.21	-30.6	-15.28
Net Debt Issued (Repaid)	-0.57	-0.61	-0.21	-0.6	-0.28
Issuance of Common Stock	-	2.6	2.13	-	-
Financing Cash Flow	-0.57	1.99	1.91	-0.6	-0.28
Net Cash Flow	-0.29	-4.87	-10.24	5.74	-1.21
Free Cash Flow	0.28	-4.24	-12.17	6.33	-0.93
Free Cash Flow Margin	0.63%	-6.26%	-26.66%	12.56%	-1.76%
Free Cash Flow Per Share	0.01	-0.14	-0.46	0.28	-0.04
Cash Interest Paid	0.69	0.7	0.87	0.95	1.06
Cash Income Tax Paid	0.05	1.04	0.08	0.06	-0.06
Levered Free Cash Flow	3.15	-3.7	-9.62	7.33	-2.89
Unlevered Free Cash Flow	3.58	-3.26	-9.08	7.91	-2.24
Change in Working Capital	3.74	-5.84	-12.19	7.58	-3.38

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.